noscript

News and Announcements

OncoSil Medical’s CEO Presents at ASX CEO Session

  • Published November 17, 2015 4:37PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

17th November 2015, ASX Announcement

Developing implantable radiotherapy medical device 

  • 30 micron silicon particles contain beta emitting phosphorous (P32)
  • Safer and stronger medical radiation treatment than external beam radiation

Successfully developed – preparing for EU commercialisation 

  • Four pilot clinical studies completed
    -2 in primary liver/ hepatcellular carcinoma
    -2 in pancreatic cancer
  • Excellent results to support Conformité Européene (CE) Marketing filings for both primary liver and pancreatic cancer & US FDA IDE submission
  • Safety evaluations suggest that OncoSil is well tolerated in patients with unresectable primary liver and pancreatic cancer
  • Efficacy data showed that OncoSil induces significant reduction in tumour volume in both liver and pancreas cancer and significantly reduces pain

To view the full presentation, please click here

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now